A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19

Clinical trial NCT04515147 · COMPLETED

Trial details

NCT number: NCT04515147
Sponsor: CureVac
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Coronavirus Covid19 SARS-CoV-2 Severe Acute Respiratory Syndrome

Start date: 2020-09-21
Primary completion: 2022-02-21
Enrollment: 668

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.